Skip to content

TightRail Mini Rotating Dilator Sheath 540-011Recalls & reported problems

Spectranetics Corporation · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00813132021627), received between Feb 12, 2020 and Oct 23, 2023 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Mechanical Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Mechanical Problem1

Patient problems

  • Great Vessel Perforation1
  • Iatrogenic Source1
  • No Known Impact Or Consequence To Patient1
  • Pericardial Effusion1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 23, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A LEAD EXTRACTION PROCEDURE COMMENCED TO REMOVE TWO RIGHT VENTRICULAR (RV) LEADS (ONE ABANDONED AND THE OTHER ONE ACTIVE AND LUMENLESS) FOR AN UPGRADE TO A CRT-D SYSTEM. A RIGHT ATRIAL (RA) LEAD WAS ALSO PRESENT IN THE PATIENT, BUT WAS NOT TARGETED FOR EXTRACTION. A SPECTRANETICS LEAD LOCKING DEVICE (LLD EZ) WAS INSERTED INTO THE ABANDONED RV LEAD TO PROVIDE TRACTION. BEGINNING WITH A SPECTRANETICS 14F GLIDELIGHT LASER SHEATH AND A SPECTRANETICS MEDIUM VISISHEATH DILATOR SHEATH, PROGRESS STALLED IN THE INNOMINATE REGION. THEN, A SPECTRANETICS 11F TIGHTRAIL MINI ROTATING DILATOR SHEATH WAS USED TO PROGRESS SLOWLY INTO THE SUPERIOR VENA CAVA (SVC), WITH ADVANCEMENT BEING DIFFICULT DUE TO TIGHT SPACE WITHIN THE VASCULATURE. THE PATIENT''S BLOOD PRESSURE DROPPED AND TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE) CONFIRMED THE PRESENCE OF A PERICARDIAL EFFUSION. RESCUE EFFORTS BEGAN, INCLUDING RESCUE BALLOON AND STERNOTOMY. A SMALL (APPROXIMATELY 1-1 1/2 CM) SVC LATERAL WALL PERFORATION WAS DISCOVERED AND REPAIRED. AFTER REPAIR WAS COMPLETED, A 13F TIGHTRAIL WAS USED POST-STERNOTOMY TO ATTEMPT REMOVAL OF THE ABANDONED RV LEAD. HOWEVER, WHEN THE TIGHTRAIL ADVANCED TO THE AREA OF INJURY, THE PERF

    Patient problems: Great Vessel Perforation; Pericardial Effusion

    MAUDE report 17992728 ↗
  • MalfunctionFeb 12, 2020Mechanical Problem; Mechanical Problem

    A LEAD EXTRACTION PROCEDURE COMMENCED TO REMOVE ONE RIGHT VENTRICLE (RV) LEAD DUE TO NON FUNCTION; FIVE OTHER LEADS WERE PRESENT BUT THEY WERE NOT TARGETED FOR EXTRACTION. THE SUBCLAVIAN TO SUPERIOR VENA CAVA (SVC) WAS OCCLUDED MAKING IT DIFFICULT TO ADVANCE A SPECTRANETICS 14F GLIDELIGHT LASER SHEATH. SINCE THE GLIDELIGHT WAS UNABLE TO MOVE THROUGH THE SUBCLAVIAN, A SPECTRANETICS 11F TIGHTRAIL MINI WAS USED TO CLEAR THE OCCLUSION. AFTER ADVANCEMENT WAS MADE WITH THE TIGHTRAIL MINI, A SPECTRANETICS 16F GLIDELIGHT LASER SHEATH AND SPECTRANETICS VISISHEATH WERE INTRODUCED INTO THE SUBCLAVIAN. THE GLIDELIGHT LASER AND VISISHEATH THEN STALLED MAKING LITTLE TO NO PROGRESS. AFTER THE GLIDELIGHT LASER AND VISISHEATH STALLED THE TIGHTRAIL MINI WAS REINTRODUCED BACK INTO THE SUBCLAVIAN. THIS DEVICE MADE SLOW PROGRESS THROUGH THE OCCLUSION. IT WAS DURING THIS ADVANCEMENT THAT THE HANDLE OF THE TIGHTRAIL MINI STOPPED TRIGGERING MAKING THE BLADES UNABLE TO ACTUATE. A NEW SPECTRANETICS 11FR TIGHTRAIL MINI WAS INTRODUCED BACK INTO THE SUBCLAVIAN, THIS NEW TIGHTRAIL MINI MADE SLOW PROGRESS AND THEN STALLED. THE PHYSICIAN THEN ELECTED TO TRY A SPECTRANETICS 13F TIGHTRAIL SUB-C DEVICE FOLLOWED BY A

    Patient problems: Iatrogenic Source; No Known Impact Or Consequence To Patient

    MAUDE report 9700048 ↗

Other Dilator, Vessel, For Percutaneous Catheterization devices

All Dilator, Vessel, For Percutaneous Catheterization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page